Scientists find small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa

Scientists find small regions of the brain can take micro-naps while the rest of the brain is awake and vice versabyUniversity of California - Santa CruzHengen's artistic interpretation of t

Updated on: July 17,2024

Scientists find small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa

Scientists find small regions of the brain can take micro-naps while the rest of the brain is awake and vice versabyUniversity of California - Santa CruzHengen's artistic interpretation of t

Updated on:July 17,2024

Ultra-thin, flexible probe provides neural interface that's minimally invasive and long-lasting

by University of California - San DiegoA small capsule supporting the neural probe, with a closeup of the microfiber tip. Credit: Spencer WardResearchers at the University of California San Diego

Updated on: February 05,2024

Ultra-thin, flexible probe provides neural interface that's minimally invasive and long-lasting

by University of California - San DiegoA small capsule supporting the neural probe, with a closeup of the microfiber tip. Credit: Spencer WardResearchers at the University of California San Diego

Updated on:February 05,2024

Alzheimer's and COVID-19 share a genetic risk factor

by University College LondonCredit: Pixabay/CC0 Public DomainAn anti-viral gene that impacts the risk of both Alzheimer's disease and severe COVID-19 has been identified by a UCL-led research

Updated on: April 08,2024

Alzheimer's and COVID-19 share a genetic risk factor

by University College LondonCredit: Pixabay/CC0 Public DomainAn anti-viral gene that impacts the risk of both Alzheimer's disease and severe COVID-19 has been identified by a UCL-led research

Updated on:April 08,2024

Race of people given Alzheimer's blood tests may affect interpretation of results

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainThree experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently

Updated on: June 24,2024

Race of people given Alzheimer's blood tests may affect interpretation of results

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainThree experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently

Updated on:June 24,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on: April 10,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on:April 10,2024

Dementia: Catching the memory thief

by University of CambridgeCredit: CC0 Public DomainIt's over a hundred years since the first case of Alzheimer's disease was diagnosed. Since then we've learned a great deal about the

Updated on: May 11,2024

Dementia: Catching the memory thief

by University of CambridgeCredit: CC0 Public DomainIt's over a hundred years since the first case of Alzheimer's disease was diagnosed. Since then we've learned a great deal about the

Updated on:May 11,2024

Key gene in familial Alzheimer's disease regulates neuronal development

by Autonomous University of BarcelonaAn international team of researchers led by the Institute of Neuroscience at the Universitat Autònoma de Barcelona describes a new route that promotes differe

Updated on: March 07,2024

Key gene in familial Alzheimer's disease regulates neuronal development

by Autonomous University of BarcelonaAn international team of researchers led by the Institute of Neuroscience at the Universitat Autònoma de Barcelona describes a new route that promotes differe

Updated on:March 07,2024

Novel method facilitates study of oxidized lipids involved in neurodegenerative diseases

NOVEMBER 15, 2023byFAPESPGraphical abstract. Credit:Free Radical Biology and Medicine(2023). DOI: 10.1016/j.freeradbiomed.2023.08.019Lipids are a diversified class of biomolecules wi

Updated on: March 28,2024

Novel method facilitates study of oxidized lipids involved in neurodegenerative diseases

NOVEMBER 15, 2023byFAPESPGraphical abstract. Credit:Free Radical Biology and Medicine(2023). DOI: 10.1016/j.freeradbiomed.2023.08.019Lipids are a diversified class of biomolecules wi

Updated on:March 28,2024

Dementia healthcare must adapt to tackle global dementia crisis

by King's College LondonA new report from Alzheimer's Disease International, authored by researchers at King's College London and the London School of Economics and Political Science

Updated on: March 09,2024

Dementia healthcare must adapt to tackle global dementia crisis

by King's College LondonA new report from Alzheimer's Disease International, authored by researchers at King's College London and the London School of Economics and Political Science

Updated on:March 09,2024

Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

by Universitaet TübingenAmyloid proteins (plaques, blue) in the cerebral cortex of a mouse model of Alzheimer’s disease, surrounded by cortical immune cells (microglia, green). Activated microgli

Updated on: April 16,2024

Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

by Universitaet TübingenAmyloid proteins (plaques, blue) in the cerebral cortex of a mouse model of Alzheimer’s disease, surrounded by cortical immune cells (microglia, green). Activated microgli

Updated on:April 16,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on: March 13,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on:March 13,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Updated on: February 27,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Updated on:February 27,2024